The authors highlight that to their knowledge this is the first trial to report report a significant, independent association between lower vitamin D levels and poorer melanoma survival. They recommend that additional investigation is needed to determine whether supplementation of vitamin D and/or interventions to reduce maladaptive systemic inflammation could be beneficial to patients with melanoma.